Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-FR Version v2-FR
Language French French
Date Updated 2019-10-07 2017-03-11
Drug Identification Number 02386054 02386054
Brand name APO-ELETRIPTAN APO-ELETRIPTAN
Common or Proper name ELETRIPTAN ELETRIPTAN
Company Name APOTEX INC APOTEX INC
Ingredients ELETRIPTAN ELETRIPTAN
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 6 BLS 6 BLS
ATC code N02CC N02CC
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2014-10-01 2014-10-01
Estimated end date 2019-12-13 2017-07-31
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments